Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • A correction to this paper has been published: https://doi.org/10.1007/s00277-021-04545-5

authors

  • Heuser, Michael
  • Smith, B Douglas
  • Fiedler, Walter
  • Sekeres, Mikkael A
  • Montesinos, Pau
  • Leber, Brian
  • Merchant, Akil
  • Papayannidis, Cristina
  • Pérez-Simón, José A
  • Hoang, Caroline J
  • O’Brien, Thomas
  • Ma, Weidong Wendy
  • Zeremski, Mirjana
  • O’Connell, Ashleigh
  • Chan, Geoffrey
  • Cortes, Jorge E

publication date

  • July 2021